Home›Research›Compare›Cagrilintide vs Retatrutide
Peptide ComparisonCagrilintide vs Retatrutide
Both are Metabolic peptides.
Cagrilintide
AM833
Half-life: ~7 days
21 providers listed
Retatrutide
GLP-3
Half-life: ~6 days
96 providers listed
Retatrutide is carried by more providers on PeptideBase (96 vs 21); otherwise the two are closely matched on the measures we track.
Cagrilintide
Half-life
~7 days
Retatrutide
Half-life
~6 days
| Your goal | Better option |
|---|---|
| More provider options (21 vs 96) | Retatrutide |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Cagrilintide
Retatrutide
Cagrilintide
Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A N…
Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with o…
Combination of cagrilintide and semaglutide 2·4 mg for weight management in adults with overweight and obesit…
Cagrilintide 2·4 mg once-weekly subcutaneous injection in adults with overweight or obesity (SCALE-CAGRI): a…
+5 more
Retatrutide
Benefits and Harms of Pharmacologic Treatments in Adults With Overweight or Obesity: A Living Systematic Revi…
Retatrutide And Lipid And Metabolite Profiles In Participants With Obesity With Or Without Type 2 Diabetes.
Design of the TRIUMPH phase 3 clinical trial programme for retatrutide in obesity and cardiometabolic disease
Triple-hormone-receptor agonist retatrutide for obesity — a phase 2 trial
+6 more
About Cagrilintide
Long-acting amylin analogue; acts on amylin/calcitonin receptors to prolong satiety; synergistic with semaglutide in CagriSema combination
About Retatrutide
Triple GIP/GLP-1/glucagon receptor agonist; targets three pathways for synergistic fat reduction
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Cagrilintide
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Given mechanistic overlap with GLP-1 agonists when used as CagriSema, monitor thyroid C-cell markers (calcitonin), lipase for pancreatitis risk, and a baseline metabolic panel. Amylin-specific monitoring guidance is evolving as Phase 3 data matures; follow prescribing protocol of the co-administered agent.
Retatrutide
Class-based (investigational)
Cagrilintide
Retatrutide
Where to source these peptides
Cagrilintide
21 listed
Browse directory →
Providers offeringRetatrutide
96 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Metabolic Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Cagrilintide vs Retatrutide — Per-mg Price Comparison. Retrieved September 12, 2026, from https://peptidebase.io/peptides/compare/cagrilintide/retatrutide